StockData

Aspira Women's Health Inc. (AWHL) stock

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health gross margin

Gross margin is gross profit as a percentage of revenue.

Aspira Women's Health's gross margin for the twelve months ending Jun 30, 2026 was 2954.7%. For fiscal 2025 it was 1724.5%, against 136975.0% the year before. The highest annual figure on record is 136975.0% in fiscal 2024.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20251724.5%−135250.5
FY2024Dec 31, 2024136975.0%+136969.0
FY2023Dec 31, 20236.0%−46.8
FY2022Dec 31, 202252.8%+7.9
FY2021Dec 31, 202145.0%+18.4
FY2020Dec 31, 202026.6%+0.2
FY2019Dec 31, 201926.3%+29.2
FY2018Dec 31, 2018-2.9%−9.5
FY2017Dec 31, 20176.6%+8.8
FY2016Dec 31, 2016-2.1%+3.9
FY2015Dec 31, 2015-6.1%−57.3
FY2014Dec 31, 201451.2%−42.2
FY2013Dec 31, 201393.4%−0.4
FY2012Dec 31, 201293.7%+0.5
FY2011Dec 31, 201193.3%+0.8
FY2010Dec 31, 201092.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 20266652.9%+5745.2
Q1 FY2026Mar 31, 20263346.9%+3286.8
Q4 FY2025Dec 31, 20254493.8%+4435.1
Q3 FY2025Sep 30, 20251553.9%+1497.5
Q2 FY2025Jun 30, 2025907.7%+906.2
Q3 FY2024Sep 30, 202460.0%+1.1
Q2 FY2024Jun 30, 202458.6%−3.6
Q1 FY2024Mar 31, 202456.4%+5.2
Q4 FY2023Dec 31, 20231.5%−56.1
Q3 FY2023Sep 30, 202359.0%+3.2
Q2 FY2023Jun 30, 202362.2%+15.5
Q1 FY2023Mar 31, 202351.2%+0.4
Q4 FY2022Dec 31, 202257.6%+2.8
Q3 FY2022Sep 30, 202255.8%+10.8
Q2 FY2022Jun 30, 202246.8%+8.1
Q1 FY2022Mar 31, 202250.8%+10.5
Q4 FY2021Dec 31, 202154.8%+38.8
Q3 FY2021Sep 30, 202145.0%+10.1
Q2 FY2021Jun 30, 202138.7%+18.2
Q1 FY2021Mar 31, 202140.3%+5.9
Q4 FY2020Dec 31, 202016.0%−23.5
Q3 FY2020Sep 30, 202034.9%+8.7
Q2 FY2020Jun 30, 202020.5%+0.0
Q1 FY2020Mar 31, 202034.4%+20.9
Q4 FY2019Dec 31, 201939.4%+21.1
Q3 FY2019Sep 30, 201926.1%+26.7
Q2 FY2019Jun 30, 201920.5%+34.6
Q1 FY2019Mar 31, 201913.6%+37.3
Q4 FY2018Dec 31, 201818.3%+7.8
Q3 FY2018Sep 30, 2018-0.5%+10.9
Q2 FY2018Jun 30, 2018-14.1%−36.8
Q1 FY2018Mar 31, 2018-23.7%−23.6
Q4 FY2017Dec 31, 201710.5%+5.7
Q3 FY2017Sep 30, 2017-11.4%+19.7
Q2 FY2017Jun 30, 201722.7%–
Q1 FY2017Mar 31, 2017-0.1%–
Q4 FY2016Dec 31, 20164.8%–
Q3 FY2016Sep 30, 2016-31.1%–

More Aspira Women's Health figures

See a number that looks wrong?